Lucid Diagnostics (LUCD) Competitors

Butterfly Network (NYSE:BFLY) and Lucid Diagnostics (NASDAQ:LUCD) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

Which has more risk and volatility, BFLY or LUCD?

Butterfly Network has a beta of 2.47, meaning that its share price is 147% more volatile than the S&P 500. Comparatively, Lucid Diagnostics has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500.

Do institutionals & insiders hold more shares of BFLY or LUCD?

37.9% of Butterfly Network shares are owned by institutional investors. Comparatively, 74.0% of Lucid Diagnostics shares are owned by institutional investors. 25.2% of Butterfly Network shares are owned by insiders. Comparatively, 6.8% of Lucid Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Do analysts recommend BFLY or LUCD?

Butterfly Network currently has a consensus price target of $3.50, suggesting a potential upside of 80.41%. Lucid Diagnostics has a consensus price target of $3.55, suggesting a potential upside of 222.73%. Given Lucid Diagnostics' stronger consensus rating and higher possible upside, analysts clearly believe Lucid Diagnostics is more favorable than Butterfly Network.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Butterfly Network	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Lucid Diagnostics	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.20

Is BFLY or LUCD more profitable?

Butterfly Network has a net margin of -75.56% compared to Lucid Diagnostics' net margin of -1,699.86%. Lucid Diagnostics' return on equity of 0.00% beat Butterfly Network's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Butterfly Network	-75.56%	-29.97%	-21.13%
Lucid Diagnostics	-1,699.86%	N/A	-124.27%

Which has preferable valuation and earnings, BFLY or LUCD?

Lucid Diagnostics has lower revenue, but higher earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than Lucid Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Butterfly Network	$82.06M	5.85	-$72.49M	-$0.29	-6.69
Lucid Diagnostics	$4.35M	27.36	-$45.53M	-$1.34	-0.82

Does the media favor BFLY or LUCD?

In the previous week, Butterfly Network had 2 more articles in the media than Lucid Diagnostics. MarketBeat recorded 3 mentions for Butterfly Network and 1 mentions for Lucid Diagnostics. Lucid Diagnostics' average media sentiment score of 1.87 beat Butterfly Network's score of 0.50 indicating that Lucid Diagnostics is being referred to more favorably in the news media.

Company	Overall Sentiment
Butterfly Network	Positive
Lucid Diagnostics	Very Positive

Summary

Lucid Diagnostics beats Butterfly Network on 10 of the 17 factors compared between the two stocks.